Search - tctmd.com

Displaying 161 - 180 of 251

Sort: Relevancy | Date

News Daily News

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

Shelley Wood

October 03, 2016

News Daily News

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

Shelley Wood

October 03, 2016

News Daily News

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Shelley Wood

October 03, 2016

News Industry News

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

September 20, 2016

News Daily News

Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins

Todd Neale

September 19, 2016

News Daily News

Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows

Yael L. Maxwell

September 15, 2016

News Industry News

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

September 15, 2016

News Daily News

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Yael L. Maxwell

July 27, 2016

News Daily News

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Yael L. Maxwell

June 20, 2016

News Daily News

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Michael O'Riordan

June 09, 2016

News Conference News SCAI 2016

Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding

L.A. McKeown

May 05, 2016

News Daily News

深入调查发现 PCI 中的出血规避策略对结局影响不大

Yael L. Maxwell

April 25, 2016

News Daily News

Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados

Yael L. Maxwell

April 25, 2016

News Daily News

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Shelley Wood

April 18, 2016

News Daily News

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

Shelley Wood

April 18, 2016

News Daily News

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Shelley Wood

April 18, 2016

News Conference News ACC 2016

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Michael O'Riordan

April 03, 2016

News Industry News

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

February 22, 2016

News Daily News

FDA: No Cardiovascular Event Reduction Claim for Ezetimibe

Shelley Wood

February 16, 2016

News Daily News

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Yael L. Maxwell

December 22, 2015

Advertisement

比伐卢定和普通肝素对有无 ST 段抬高的 ACS 患者没有任何差异：MATRIX

No Differences Between Bivalirudin, Unfractionated Heparin in ACS Patients With or Without ST Elevation: MATRIX

MATRIX: No Hay Diferencias entre Bivalirudina y Heparina No Fraccionada en Pacientes SCA Con o Sin Elevación del Segmento ST

Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab)

Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins

Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers

Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected?

Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests

Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel

Bleeding Calculator Use Linked to Dramatic Decrease in Post-PCI Bleeding

深入调查发现 PCI 中的出血规避策略对结局影响不大

Un Análisis Certero de Estrategias para la Evitación de Hemorragias en PCI Revela Poco Impacto en los Resultados

比伐卢定标签更新，警告 STEMI 患者 PCI 后的急性支架血栓事件，建议持续输液

Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion

La Actualización del Prospecto de Bivalirudina Advierte del Riesgo de Trombosis Aguda de Stent con PCI para el Manejo de STEMI y Recomienda la Infusión Continuada

Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH

Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference

FDA: No Cardiovascular Event Reduction Claim for Ezetimibe

Triple Therapy, Especially With Prasugrel, Increases Bleeding Risk in Acute MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content